Sumitomo Pharma Co., Ltd. Logo

Sumitomo Pharma Co., Ltd.

Pharmaceutical R&D company focused on neurology, psychiatry, and oncology.

4506 | T

Overview

Corporate Details

ISIN(s):
JP3495000006
LEI:
Country:
Japan
Address:
大阪市中央区道修町2丁目6番8号

Description

Sumitomo Pharma Co., Ltd. is a research and development-driven pharmaceutical company focused on creating innovative pharmaceuticals and healthcare solutions. The company's primary therapeutic areas are Psychiatry & Neurology and Oncology, with additional activities in diabetes, rare diseases, and women's health. A key aspect of its R&D strategy is the integration of established expertise in small molecule drug discovery with pioneering modalities such as regenerative medicine and cell therapy. The company's mission is to translate scientific innovation into real-world solutions to contribute to the betterment of healthcare and fuller lives for people worldwide, with a strategic business focus on Japan and the United States.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-11-04 08:19
確認書
Japanese ZIP 8.7 KB
2025-11-04 08:13
半期報告書-第206期(2025/04/01-2025/09/30)
Japanese ZIP 319.2 KB
2025-10-31 08:39
訂正臨時報告書
Japanese ZIP 41.0 KB
2025-06-27 09:05
臨時報告書
Japanese ZIP 29.6 KB
2025-06-26 09:39
確認書
Japanese ZIP 8.7 KB
2025-06-26 09:36
内部統制報告書-第205期(2024/04/01-2025/03/31)
Japanese ZIP 24.0 KB
2025-06-26 09:31
有価証券報告書-第205期(2024/04/01-2025/03/31)
Japanese ZIP 2.1 MB
2025-05-30 09:41
訂正臨時報告書
Japanese ZIP 40.7 KB
2025-05-14 09:18
訂正臨時報告書
Japanese ZIP 36.6 KB
2025-04-28 10:06
訂正臨時報告書
Japanese ZIP 24.3 KB
2025-04-28 10:03
臨時報告書
Japanese ZIP 19.0 KB
2025-04-03 09:39
臨時報告書
Japanese ZIP 41.7 KB
2025-01-31 08:11
臨時報告書
Japanese ZIP 18.7 KB
2024-12-19 07:19
臨時報告書
Japanese ZIP 19.2 KB
2024-11-01 03:30
確認書
Japanese ZIP 8.7 KB

Automate Your Workflow. Get a real-time feed of all Sumitomo Pharma Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Sumitomo Pharma Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Sumitomo Pharma Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.